Breaking News Instant updates and real-time market news.

TGTX

TG Therapeutics

$6.05

0.15 (2.54%)

08:49
11/22/16
11/22
08:49
11/22/16
08:49

TG Therapeutics says DSMB recommends continuation of UNITY-CLL Phase 3 trial

TG Therapeutics announced that the independent Data Safety Monitoring Board, or DSMB, providing oversight for the UNITY-CLL Phase 3 trial reviewed the cumulative safety data from the ongoing clinical study and informed the company that it has identified no safety concerns, and recommended the continuation of the study with no modifications. Per the protocol's pre-specified DSMB charter, the DSMB is scheduled to meet approximately every 6-9 months to review cumulative safety data. "We are encouraged by the positive outcome of the first DSMB safety review, especially since over two-thirds of the patients currently enrolled in the study are treatment naive CLL patients. Many may recall, as reported by Dr. Jennifer Brown at last year's ASH meeting, and published earlier this year in Blood, that idelalisib in treatment naive CLL patients was observed to cause rapid (most within less than5 weeks) and profound (Grade 3/4) liver toxicity in approximately 50% of the patients treated. Given those findings, we are pleased to report that the DSMB did not find any safety concerns and recommended the study continue without modification. We are also excited to report that the UNITY-CLL study continues to enroll well and we are still targeting completion of enrollment in the first half of 2018," stated Executive Chairman and Interim CEO Michael Weiss.

  • 03

    Dec

TGTX TG Therapeutics
$6.05

0.15 (2.54%)

05/27/16
RHCO
05/27/16
INITIATION
Target $18
RHCO
Buy
TG Therapeutics initiated with a Buy at SunTrust
SunTrust analyst Yatin Suneja initiated TG Therapeutics with a Buy rating and $18 price target.
10/06/16
BMUR
10/06/16
INITIATION
Target $28
BMUR
Buy
TG Therapeutics assumed coverage with a Buy at Brean Capital
Brean Capital analyst Jason Wittes assumed coverage on TG Therapeutics with a Buy and $28 price target.
10/13/16
ROTH
10/13/16
NO CHANGE
Target $33
ROTH
Buy
Roth Capital remains a buyer of TG Therapeutics after GENUINE announcement
After TG Therapeutics announced that it amended the Phase 3 GENUINE study to have overall response rate as the primary endpoint, Roth Capital analyst Joseph Pantginis says the company is making the hard but right decision. While perceptions are negative on trial amendments, the analyst believes this clarity on timelines, the robustness of Phase 2 data and important drug approval precedents continue to point to a positive outcome for the study. Pantginis believes TG Therapeutics' shares are being oversold, and reiterates a Buy rating and $33 price target on the stock. In late morning trading, shares of TG Therapeutics have dropped more than 14% to $7.07.
10/14/16
HCWC
10/14/16
NO CHANGE
Target $18
HCWC
Buy
TG Therapeutics study changes should be no surprise, says H.C. Wainwright
In a research note titled "The Best Way to Pull Off a Band Aid Is Quickly," H.C. Wainwright analyst Andrew Fein says the changes TG Therapeutics announced yesterday to the GENUINE study were "necessary, timely, and, generally, should have not been a surprise" based on the last two quarterly updates. The protocol changes effectively dissolve the Special Protocol Agreement covering the study, which does increase the perceived regulatory risk even upon a study win, Fein tells investors in a research note. He lowered his price target for TG shares to $18 from $22 and keeps a Buy rating on the name. The analyst notes that removing the GENUINE program from his valuation would lead to a $16 price target.

TODAY'S FREE FLY STORIES

OIH

Oil Services Holders Trust

$24.35

-0.02 (-0.08%)

10:00
06/27/17
06/27
10:00
06/27/17
10:00
Options
VanEck Vectors Oil Services ETF with notable option action »

VanEck Vectors Oil…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:00
06/27/17
06/27
10:00
06/27/17
10:00
General news
U.S. Consumer Confidence Preview: »

U.S. Consumer Confidence…

COST

Costco

$160.20

3.07 (1.95%)

09:59
06/27/17
06/27
09:59
06/27/17
09:59
Conference/Events
Costco management to meet with Deutsche Bank »

Field trip to company…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 23

    Aug

AA

Alcoa

$31.97

0.79 (2.53%)

09:57
06/27/17
06/27
09:57
06/27/17
09:57
Recommendations
Alcoa analyst commentary  »

Alcoa price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

K

Kellogg

$70.16

-0.83 (-1.17%)

09:55
06/27/17
06/27
09:55
06/27/17
09:55
Options
Kellogg put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CCI

Crown Castle

$103.16

3.41 (3.42%)

, DRI

Darden

$92.62

2.54 (2.82%)

09:55
06/27/17
06/27
09:55
06/27/17
09:55
Options
Early notable gainers among liquid option names on June 27th »

Notable gainers among…

CCI

Crown Castle

$103.16

3.41 (3.42%)

DRI

Darden

$92.62

2.54 (2.82%)

KSS

Kohl's

$38.27

0.75 (2.00%)

M

Macy's

$22.76

0.2944 (1.31%)

AMT

American Tower

$135.11

2.65 (2.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 18

    Jul

  • 19

    Jul

  • 21

    Sep

NDAQ

Nasdaq

$70.30

0.44 (0.63%)

, CBOE

CBOE Holdings

$89.62

0.85 (0.96%)

09:55
06/27/17
06/27
09:55
06/27/17
09:55
Conference/Events
House Financial Services Committee to hold a hearing Nasdaq CBOE Holdings Charles Schwab »

The Capital Markets,…

NDAQ

Nasdaq

$70.30

0.44 (0.63%)

CBOE

CBOE Holdings

$89.62

0.85 (0.96%)

SCHW

Charles Schwab

$42.35

0.5 (1.19%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 26

    Jul

CME

CME Group

$123.65

-0.47 (-0.38%)

, CS

Credit Suisse

$14.23

0.26 (1.86%)

09:55
06/27/17
06/27
09:55
06/27/17
09:55
Conference/Events
House Agriculture Committee to hold a hearing »

The Committee holds a…

CME

CME Group

$123.65

-0.47 (-0.38%)

CS

Credit Suisse

$14.23

0.26 (1.86%)

ICE

IntercontinentalExchange

$64.59

0.24 (0.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 01

    Aug

KW

Kennedy Wilson

09:54
06/27/17
06/27
09:54
06/27/17
09:54
Conference/Events
Kennedy Wilson management to meet with Deutsche Bank »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

IRBT

iRobot

$100.98

-0.22 (-0.22%)

09:52
06/27/17
06/27
09:52
06/27/17
09:52
Periodicals
iRobot mentioned cautiously by Spruce Point Capital 

Reference Link

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INFO

IHS Markit

$46.40

-0.15 (-0.32%)

09:51
06/27/17
06/27
09:51
06/27/17
09:51
Conference/Events
IHS Markit management to meet with Deutsche Bank »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 27

    Jun

ALNY

Alnylam

$82.92

-2.29 (-2.69%)

09:50
06/27/17
06/27
09:50
06/27/17
09:50
Conference/Events
Alnylam participates in a conference call with Piper Jaffray »

Piper Jaffray Biotech…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

  • 06

    Jul

APDN

Applied DNA Sciences

$1.40

0.31 (28.44%)

09:49
06/27/17
06/27
09:49
06/27/17
09:49
Hot Stocks
Applied DNA Sciences signs new licensing agreement with Himatsingka America »

Applied DNA Sciences is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PPC

Pilgrim's Pride

$22.40

-0.44 (-1.93%)

09:45
06/27/17
06/27
09:45
06/27/17
09:45
Periodicals
Humane Society issues report making allegations on Pilgrim's Pride supply chain 

Reference Link

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:45
06/27/17
06/27
09:45
06/27/17
09:45
General news
Richmond Fed Manufacturing Index Level to be reported at 10:00 »

June Richmond Fed…

09:45
06/27/17
06/27
09:45
06/27/17
09:45
General news
Consumer Confidence to be reported at 10:00 »

June Consumer Confidence…

PFE

Pfizer

09:42
06/27/17
06/27
09:42
06/27/17
09:42
Hot Stocks
Pfizer expects to hire additional 80 employees for R&D facility in coming years »

Pfizer (PFE) broke ground…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Jul

  • 02

    Aug

  • 27

    Aug

KSS

Kohl's

09:40
06/27/17
06/27
09:40
06/27/17
09:40
Options
Kohls calls lead puts 50:1 in early chatter-driven flow »

Kohls calls lead puts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VIAB

Viacom

$35.09

0.98 (2.87%)

, OIH

Oil Services Holders Trust

09:40
06/27/17
06/27
09:40
06/27/17
09:40
Options
Unusually active option classes on open June 27th »

Unusual total active…

VIAB

Viacom

$35.09

0.98 (2.87%)

OIH

Oil Services Holders Trust

MDLZ

Mondelez

CLF

Cliffs Natural

RAD

Rite Aid

WDC

Western Digital

$92.66

-0.68 (-0.73%)

S

Sprint

KO

Coca-Cola

GM

General Motors

SLV

iShares Silver Trust

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 26

    Jul

  • 03

    Aug

  • 16

    Nov

NWS

News Corp

$14.10

0.05 (0.36%)

, NWSA

News Corp.

$13.66

0.07 (0.52%)

09:39
06/27/17
06/27
09:39
06/27/17
09:39
Hot Stocks
News Corp 'applauds' European Commission's decision to fine Google »

The following statement…

NWS

News Corp

$14.10

0.05 (0.36%)

NWSA

News Corp.

$13.66

0.07 (0.52%)

GOOG

Alphabet

$952.27

-13.32 (-1.38%)

GOOGL

Alphabet Class A

$972.09

-14 (-1.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 28

    Jun

  • 19

    Jul

BAP

Credicorp

09:35
06/27/17
06/27
09:35
06/27/17
09:35
Downgrade
Credicorp rating change  »

Credicorp downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CUTR

Cutera

$25.90

1.4 (5.71%)

09:35
06/27/17
06/27
09:35
06/27/17
09:35
Recommendations
Cutera analyst commentary  »

Cutera named a 2H 2017…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

  • 30

    Jun

  • 28

    Sep

09:35
06/27/17
06/27
09:35
06/27/17
09:35
General news
U.S. equities are set to open lower »

U.S. equities are set to…

STX

Seagate

$42.39

-0.28 (-0.66%)

09:34
06/27/17
06/27
09:34
06/27/17
09:34
Technical Analysis
Technical View: Seagate falls in early trading »

The stock was last down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SO

Southern Company

09:32
06/27/17
06/27
09:32
06/27/17
09:32
Hot Stocks
Southern Company announces strategic alliance with Advanced Microgrid Solutions »

Southern Company…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.